What is the treatment for Staphylococcus epidermidis infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Staphylococcus epidermidis Infections

For S. epidermidis infections, initiate empiric vancomycin therapy while awaiting susceptibility results, then switch to a semisynthetic penicillin (such as nafcillin or oxacillin) if the isolate is methicillin-susceptible. 1, 2

Initial Empiric Therapy

  • Start vancomycin immediately for any serious S. epidermidis infection when methicillin resistance cannot be ruled out, as this is the treatment of choice for suspected methicillin-resistant organisms 1, 2
  • Vancomycin should be continued empirically because 70-90% of S. epidermidis clinical isolates are methicillin-resistant 3
  • PCR results can identify Staphylococcus species approximately 39 hours earlier than conventional methods, allowing for more rapid targeted therapy 2

Definitive Therapy Based on Susceptibility

  • For methicillin-susceptible S. epidermidis: Switch to a semisynthetic penicillinase-resistant penicillin (nafcillin, oxacillin) or first-generation cephalosporin once susceptibility is confirmed 1, 4
  • For methicillin-resistant S. epidermidis: Continue vancomycin as the drug of choice 1, 4
  • For serious methicillin-resistant infections, consider combination therapy with vancomycin plus rifampin or gentamicin, though routine combination therapy is not recommended for uncomplicated cases 1, 4

Device-Related Infections: Critical Management Decisions

The presence of an indwelling device fundamentally changes treatment strategy, as S. epidermidis forms biofilms that are notoriously resistant to antibiotics alone. 5

For Non-Tunneled Central Venous Catheters (CVCs):

  • Remove the catheter and treat with systemic antibiotics for 5-7 days if removal is feasible 1
  • If the catheter must be retained and intraluminal infection is suspected, use systemic antibiotics for 10-14 days plus antibiotic lock therapy 1

For Tunneled CVCs or Implanted Devices:

  • The catheter can be retained in uncomplicated catheter-related bloodstream infections 1
  • If retained, treat with systemic antibiotics for 7 days plus antibiotic lock therapy for 14 days 1
  • Remove the device immediately if any of the following occur: persistent fever, persistently positive blood cultures, or relapse after antibiotic discontinuation 1

For Prosthetic Cardiac Devices:

  • Perioperative prophylaxis should be directed primarily against staphylococci with a first-generation cephalosporin 1
  • In hospitals with high prevalence of methicillin-resistant S. epidermidis, vancomycin may be considered for surgical prophylaxis, though it has not been proven superior to cephalosporins 1
  • Prophylaxis should be initiated immediately before surgery and continued for no more than 48 hours postoperatively 1

Assessing Clinical Significance vs. Contamination

A single positive blood culture for coagulase-negative staphylococci (including S. epidermidis) may represent contamination rather than true infection. 2

  • Do not treat if only one blood culture is positive and other cultures are negative, as this likely represents contamination 2
  • True S. epidermidis bacteremia typically presents with fever alone or fever with inflammation at catheter exit sites, and most patients have a benign clinical course 1
  • Consider the clinical context: immunocompromised patients, presence of indwelling devices, and multiple positive cultures support true infection 4, 6

Duration of Therapy

  • Without device removal: 10-14 days of systemic therapy for non-tunneled catheters; 7 days systemic plus 14 days antibiotic lock therapy for tunneled catheters 1
  • With device removal: 5-7 days of systemic antibiotics for uncomplicated infections 1
  • Treatment duration should be extended if complications develop or if the patient has persistent symptoms 1

Common Pitfalls to Avoid

  • Do not continue empiric vancomycin if cultures are negative for beta-lactam-resistant gram-positive organisms 2
  • Do not assume susceptibility based on standard testing alone—methicillin-resistant S. epidermidis may appear susceptible unless reliable susceptibility testing methods are used 4
  • Do not rely on antibiotics alone for device-related infections—removal of the infected device is often required for successful therapy 5, 4
  • Do not use cephalosporins for methicillin-resistant strains, as cross-resistance occurs in vitro 4

Special Considerations for Severe Penicillin Allergy

  • Vancomycin remains appropriate for patients with severe penicillin allergy who cannot receive β-lactams, even for methicillin-susceptible S. epidermidis 2

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.